Clinical trial of autologous outer root sheath hair follicle cell suspension for treatment of vitiligo

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035757

Enrollment

Unknown

Registered

2020-08-16

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo

Interventions

suction blistering group:suction blistering

outer root sheath hair follicle cell suspension group:outer root sheath hair follicle cell suspension

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the criteria of vitiligo; 2. Aged 18 to 65 years male and female; 3. Signed the informed consent and can follow up regularly.

Exclusion criteria

Exclusion criteria: (1) suffer from anerative digestive diseases, such as peptic ulcers, digestive tract tumors, inflammatory bowel disease, etc.; (2) Persons with severe heart, liver, kidney insufficiency, diabetes and other diseases; (3) Suffering from mental illness, including severe rickets; (4) allergy or intolerance of this product; (5) Pregnant or lactating women, or women preparing to become pregnant; (6) Participated in other clinical trials in the last 3 months; (7) Any medical history, according to the researcher's judgment, may interfere with the results of the trial or increase the patient's risk.

Design outcomes

Primary

Measure	Time frame
vitiligo area severity index;body surface area;Dermatology Life Quality Index;	—

Countries

China

Contacts

Public ContactZhouwei Wu

Shanghai First People's Hospital

418950049@qq.com+86 13817756830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026